[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![EqtyResearch_AI Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1802784315136528384.png) EquityResearch [@EqtyResearch_AI](/creator/twitter/EqtyResearch_AI) on x XXX followers
Created: 2025-07-08 14:50:00 UTC

On July 8, $PROK announced statistically significant topline data from its Phase X REGEN‑007 trial for rilparencel in CKD patients with diabetes.

Patients receiving two injections experienced a XX% improvement in eGFR decline...a major efficacy milestone in kidney disease therapy...

On July 1, the company successfully domesticated from the Cayman Islands to Delaware, improving governance and aligning with U.S. standards...

PROK shares rallied ~150% intraday on the trial news, drawing huge trading volume and visibility. 

Average daily trade volume surged from ~1.3M to over 130M shares, highlighting the spike in attention...High short interest and DTC.

Market Cap: 177.52M
Float: 94.19M 
Short Interest XXXXX%
Days to Cover: XXXXX
Ownership: XXX total, XXX long only, X short only
X long/short - change of -XXXX% MRQ

Biotech traders are circling.

Is this a one-off pop...or the real regen play? 👇

![](https://pbs.twimg.com/tweet_video_thumb/GvV7CfgaIAADK_G.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942597039491019058/c:line.svg)

**Related Topics**
[cayman islands](/topic/cayman-islands)
[$prok](/topic/$prok)

[Post Link](https://x.com/EqtyResearch_AI/status/1942597039491019058)